Biotech Briefing
-
Biotech Briefing: Verge, UC San Diego, and VIB Collaborate on Parkinson’s Research
Plus: TSRI expands its board of directors, and Luna DNA wants to trade donated DNA for dividends
Read More » -
Biotech Briefing: Will More Female Leaders Drive Innovation?
Plus: UC San Diego reports its first results from the largest microbiome study, and Illumina acquires Edico Genomics
Read More » -
Biotech Briefing: A Hepatitis C Drug Could Treat Zika Infections
Plus: 10,000 Maniacs hold concert for Parkinson’s disease research, and the influence of San Diego’s first biotech
Read More » -
Biotech Briefing: Salk Institute Scientists Develop Cell Therapy for Hemophilia
Plus: Scripps Translational Science Institute receives $34 million NIH award
Read More » -
Biotech Briefing: San Diego Is Facing an Alzheimer’s Epidemic and We’re Not Prepared
Plus: Synthetic Genomics featured in Fast Company‘s World Changing Ideas
Read More » -
Biotech Briefing: Second Annual March for Science Is This Saturday
Plus: UC San Diego microbiologist’s research helps make the best cheese, and San Diego startups raise more than 500 million venture dollars
Read More » -
Biotech Briefing: UCSD Researchers Find Non-Coding DNA Mutations Can Cause Cancer
Plus: Scripps research grad school recognized as Top 10 for chemistry and biology, and Wisconsin startup moves to San Diego
Read More » -
Biotech Briefing: TSRI Finds Rare Genetic Mutation Protects Against Malaria
Plus: Dexcom receives FDA green light for the first interoperable CGM, and the top biotech events this month
Read More » -
Biotech Briefing: Encinitas Biotech Raises $19 Million for Autoimmune Therapies
Plus: A 50-year timeline of UC San Diego’s School of Medicine, and the 2018 winners of the Greater San Diego Science and Engineering Fair
Read More » -
Biotech Briefing: ExxonMobil and Synthetic Genomics Move to Grow Algae Biofuel Outside
Plus: Are unicorns overrated, and what is the alternative?
Read More » -
Biotech Briefing: Why Can’t the Drug Industry Solve Its Gender Diversity Problem?
Plus: Vividion Therapeutics and Celgene collaborate on intractable drug targets
Read More » -
Biotech Briefing: UC San Diego Researchers Use AI to Diagnose Eye Diseases
Plus: TSRI scientists shed light on genome’s dark matter, and Fate Therapeutics wins CIRM grant
Read More » -
Biotech Briefing: FDA Approves First Objective Test for Traumatic Brain Injury
Plus: MediciNova raises $40 million to advance multiple sclerosis drug, and more San Diego biotech news
Read More » -
Biotech Briefing: Rady Children’s Hospital Sets World Record for Fastest Genome Sequencing
Plus: TSRI receives $10 million grant to find new therapies for alcohol abuse
Read More » -
Biotech Briefing: Sanford Burnham Prebys Says Off-the-Shelf Drugs Could Manage Zika
Plus: Organovo founder pays it forward, and MedCity News questions investing in oncology
Read More » -
Biotech Briefing: Synthetic Genomics Speeds up Production of Flu Vaccines
Plus: TSRI receives donation for graduate program fellowships, and UC San Diego School of Medicine turns 50
Read More » -
Biotech Briefing: UCSD Researchers Activate Cancer-Killing Cells with Ultrasound
Plus: Salk names interim president and Shanghai Pharmaceuticals plans to open research center in San Diego
Read More » -
Biotech Briefing: San Diego Startups Raised $1.93 Billion in Venture Capital in 2017
Plus: TSRI scientists find therapeutic target for Marburg virus
Read More » -
Biotech Briefing: Local Researchers Map Brain Disorders for Better Drug Development
Plus: Celgene buys Impact cancer drug, and Expansion Therapeutics plans to develop RNA-targeting drugs
Read More » -
Biotech Briefing: Gates Foundation Supports Sirenas’ Marine Drug Discovery
Plus: San Diego EDC’s top 10 stories and what to do with a genetic testing kit
Read More » -
Biotech Briefing: Ionis Licenses Huntington’s Disease Drug to Roche
Plus: Fate Therapeutics makes five announcements and Michael Pellini joins Section 32 Venture Fund
Read More »
